Skinner is a Managing Director at the General Partner of MarsBio, an early-stage biotechnology investment fund, which was acquired by Dark Matter (link to darkmatter.bio) in 2025. Skinner co-founded Dark Matter in 2020, and it has become a biotech holding company with projects in longevity venture capital, human and fungal genomics, personalized medicine, and nutritional supplements.
Skinner has more than 2.500 hours of experience as a lecturer and group facilitator in more than 25 cities, with 1.700 students from more than 50 countries. Through his teaching and mentoring work, he has conducted extensive research and developed a novel Jungian model of psychological type built on an evolutionary game-theoretical understanding of competitive bias and error preferences called the Numatas Framework.
Skinner is also the co-founder and chairman of RavenGraph, an AI startup building Graph Neural Network machine learning technology, and he is the sole founder and chief architect of Waterlight, an advanced AI research & development system derived from his psychological research, releasing its public beta in Q3 2026, and which already serves as the engine for MarsBio and Dark Matter's due diligence, market intelligence, and investor relations workflow.
In 2012, Skinner founded Exosphere, a learning and problem-solving community that conducted intensive educational programs & startup boot camps focused on deep tech & science entrepreneurship. He has also served as a mentor for Start-Up Chile and the Estonia-based Cocoon startup mentoring program.
He has spent most of his adult life living abroad, 11 years in South America—Brazil and Chile, and since 2019, has lived near Barcelona with his partner and their dogs.
"We are a tool using species - biotechnology is the greatest tool yet discovered. It will be the key to our survival here on Earth, and key to our transformation into a spacefaring civilization."
Mark is a General Partner at MarsBio, an early-stage biotechnology investment fund. He is also the co-founder and a managing partner at PacWest Partners, an early-stage Venture investment firm.
Through his family office, Six Toes Ventures, Mark has invested in over 100 companies across enterprise SaaS, blockchain, gaming, biotech and deep tech. He has also participated in dozens of token sales and NFTs. He is a multiple unicorn investor in crypto, medtech and natural resources.
Mark actively advises companies on investor relations, capital markets structuring and strategic planning.
While living as an expat for 10 years in New Zealand, Mark created the global macro blog, CapitalistExploits and formed an investment syndicate called Seraph. The syndicate consists of private investors and family offices from over a dozen countries. As a group, Seraph represented investments of over $70 mm in 50+ companies and organized and ran investor meet ups in 16+ countries over 5 years.
Mark received a Bachelor of Science degree in Public Health from Northern Illinois University in 1990. He is a dual-citizen of both the U.S. and New Zealand.
"The future of longevity lies in precision medicine, AI-driven therapies, and regenerative biology. By decoding aging at the molecular level, we'll extend healthy human lifespan beyond 120 years, transforming society and redefining what it means to live fully."
"The genetic code does not, and cannot, specify the nature and position of every capillary in the body or every neuron in the brain. What it can do is describe the underlying fractal pattern which creates them."